Dizhar Pharmaceuticals
All
Newsflash
Article
-
AstraZeneca acquires global rights to lung cancer treatment Zegfrovy from Dizal Pharmaceutical for $600 million upfront, with potential for up to $1.5 billion
AstraZeneca will pay Dizal Pharmaceutical Co., Ltd. an initial $600 million, with an additional $900 million contingent on development, regulatory, and sales milestones. Zegfrovy (sunvozertinib) is an
-
AstraZeneca acquires global rights to lung cancer treatment Zegfrovy from Dizal Pharmaceutical for $600 million upfront, with potential for up to $1.5 billion
AstraZeneca will pay Dizal Pharmaceutical Co., Ltd. an initial $600 million, with an additional $900 million contingent on development, regulatory, and sales milestones. Zegfrovy (sunvozertinib) is an
- No data
Dizhar Pharmaceuticals
Svmuu provides news and information related to Dizhar Pharmaceuticals, as well as real-time data on Dizhar Pharmaceuticals. We provide in-depth analysis and interpretation of the latest Dizhar Pharmaceuticals developments, helping investors stay informed about Dizhar Pharmaceuticals policy updates. Svmuu is your essential tool for keeping up with the latest Dizhar Pharmaceuticals trends! Here, we’ll join you in keeping a close eye on Dizhar Pharmaceuticals news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Polkadot (DOT) Ecosystem Expansion: New Projects, Core Upgrades, and Tokenomics Transformation
-
2
China's Cryptocurrency Regulatory Policies and a Global Overview of Trading Platforms
-
3
Major Global Cryptocurrency Exchanges: Market Landscape, Services, and Compliance Trends
-
4
AI Arms Race "Overwhelms" US Bond Market: SpaceX, Broadcom, Oracle Seek Over $150 Billion in Financing Within a Week, Pressuring Treasury Yields Upward
-
5
What is ClubCoin (CLUB)? Analyzing its Technical Features and Market Status
-
6
Line Thailand aims to be the country's "everyday AI app", considering building its own data center and expanding services through acquisitions
-
7
How to Choose a Secure and Reliable Bitcoin Trading Platform? Compliance and asset protection are key.
-
8
DCR Coin: Decred Token Trading Platforms and Purchase Guide
-
9
Abstract's ETH Withdrawals Depend on Operators Ahead of Dec. 15 Shutdown; $17.1M Bridged ETH Lacks Independent Exit Plan Post-Shutdown
-
10
Citrini Research: Wall Street's tokenization boom could yield bigger winners than Bitcoin and Ethereum
Markets Today
Recommended Reading






